Choice of antihypertensive drug therapy.

[1]  N. Norman,et al.  Central and renal circulation, renin and aldosterone in plasma during prazosin treatment in essential hypertension. , 2009, Acta medica Scandinavica.

[2]  G. Neugebauer,et al.  Clinical pharmacologic investigations with carvedilol, a new beta‐blocker with direct vasodilator activity , 1986, Clinical pharmacology and therapeutics.

[3]  Y. Pirson,et al.  CYCLOSPORIN-DILTIAZEM INTERACTION , 1986, The Lancet.

[4]  W. Nayler,et al.  Calcium antagonists and their mode of action: an historical overview. , 1986, British journal of clinical pharmacology.

[5]  L. Storstein,et al.  Studies on verapamil in the treatment of essential hypertension: a review. , 1986, British journal of clinical pharmacology.

[6]  D. Krikler.  The Danish studies on verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction. , 1986, British journal of clinical pharmacology.

[7]  B N Singh,et al.  The mechanism of action of calcium antagonists relative to their clinical applications. , 1986, British journal of clinical pharmacology.

[8]  H. Dargie.  Combination therapy with beta-adrenoceptor blockers and calcium antagonists. , 1986, British journal of clinical pharmacology.

[9]  F. Follath,et al.  Once a day verapamil in essential hypertension. , 1986, British journal of clinical pharmacology.

[10]  P. Weidmann,et al.  Antihypertensive treatment and serum lipoproteins. , 1985, Journal of hypertension.

[11]  W. Meyer-Sabellek,et al.  Effects of Long-term Treatment with Carvedilol (BM 14190) versus Metoprolol on Haemodynamic Parameters , 1985 .

[12]  P. Lund-johansen,et al.  Long-term haemodynamic effects of enalapril (alone and in combination with hydrochlorothiazide) at rest and during exercise in essential hypertension. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[13]  Vidt Dg.  A controlled multiclinic study to compare the antihypertensive effects of MK-421, hydrochlorothiazide, and MK-421 combined with hydrochlorothiazide in patients with mild to moderate essential hypertension. , 1984 .

[14]  R. Davies,et al.  Clinical pharmacology of enalapril. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[15]  J. Walker,et al.  Overall tolerance and safety of enalapril. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[16]  R. Eggertsen,et al.  Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension. , 1984, Journal of hypertension.

[17]  V. Shnyrov,et al.  Microcalorimetry and electrophoresis of the erythrocyte membrane of spontaneously hypertensive rats. , 1984, Journal of hypertension.

[18]  A. Doyle,et al.  Vascular prostacyclin and Goldblatt hypertensive rats. , 1984, Journal of hypertension.

[19]  E. Frohlich,et al.  DOCA-salt induced malignant hypertension in spontaneously hypertensive rats. , 1984, Journal of hypertension.

[20]  E. Ritz,et al.  47 Dietary Calcium Lowers Blood Pressure Without Accompanying Intravascular Volume Depletion , 1984 .

[21]  L. Turnbull,et al.  The Use of Nifedipine in Combination Therapy for the Management of Hypertension , 1984 .

[22]  R. Graham.  Selective alpha 1-adrenergic antagonists: therapeutically relevant antihypertensive agents. , 1984, The American journal of cardiology.

[23]  P. Corris,et al.  Nifedipine in the prevention of asthma induced by exercise and histamine. , 1983, The American review of respiratory disease.

[24]  T. Nakano,et al.  Effects of diltiazem on cardiovascular responses during exercise in systemic hypertension and comparison with propranolol. , 1983, The American journal of cardiology.

[25]  K. Yano,et al.  Thiazide effect on the mineral content of bone. , 1983, The New England journal of medicine.

[26]  J. Staessen,et al.  Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients. , 1983, American heart journal.

[27]  C. Dollery,et al.  Role of nifedipine in treatment of hypertension. , 1983, British medical journal.

[28]  A. Doyle.  Comparison of beta-adrenoceptor blockers and calcium antagonists in hypertension. , 1983, Hypertension.

[29]  R. Krebs.  Adverse reactions to calcium antagonists , 1983, Hypertension.

[30]  M. Schreiber,et al.  Renal failure associated with captopril. , 1983, JAMA.

[31]  A. Johnson,et al.  Low–dose Captopril Titration in Patients with Moderate–to–Severe Hypertension Treated with Diuretics , 1983, Circulation.

[32]  N. Markandu,et al.  Lack of effect of beta-blocker on flat dose response to thiazide in hypertension: efficacy of low dose thiazide combined with beta-blocker. , 1983, British medical journal.

[33]  R. Watson,et al.  The Effect of Nifedipine on Arterial Pressure and Reflex Cardiac Control , 1983, Circulation.

[34]  J. Drayer,et al.  Long-term BP monitoring in the evaluation of antihypertensive therapy. , 1983, Archives of internal medicine.

[35]  B. Gould,et al.  Nifedipine tablets for systemic hypertension: a study using continuous ambulatory intraarterial recording. , 1983, The American journal of cardiology.

[36]  S. Dombey.  OPTIMAL DOSE OF CAPTOPRIL IN HYPERTENSION , 1983, The Lancet.

[37]  P. Turner,et al.  Indoramin in the treatment of hypertension. A mini-review and update. , 1983, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[38]  A. Fleckenstein.  History of Calcium Antagonists , 1983, Circulation research.

[39]  U. Dubach,et al.  Nifedipine in hypertensive emergencies. , 1983, British medical journal.

[40]  J. Cooper,et al.  Thromboxane Synthesis by Sources Other Than Platelets in Association with Complement‐Induced Pulmonary Leukostasis and Pulmonary Hypertension in Sheep , 1983, Circulation research.

[41]  C.D. Smith,et al.  CONTROLLED TRIAL OF NIFEDIPINE IN THE TREATMENT OF RAYNAUD'S PHENOMENON , 1982, The Lancet.

[42]  P. Lund-johansen,et al.  Prizidilol in Essential Hypertension: Long‐Term Effects on Plasma Volume, Extracellular Fluid Volume, and Central Hemodynamics at Rest and During Exercise , 1982, Journal of cardiovascular pharmacology.

[43]  J. Tuomilehto,et al.  Treatment of Mild and Moderate Hypertension with Medroxalol, an α and β‐Adrenergic Antagonist , 1982 .

[44]  M. Blaufox,et al.  The effect of treatment on mortality in "mild" hypertension: results of the hypertension detection and follow-up program. , 1982, The New England journal of medicine.

[45]  B. Robinson,et al.  Nifedipine in the treatment of hypertension: report of a double-blind controlled trial. , 1982, British journal of clinical pharmacology.

[46]  J. Wikstrand,et al.  Antihypertensive treatment with beta-blockers in patients aged over 65. , 1982, British medical journal.

[47]  L. Opie,et al.  Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol. , 1982, American heart journal.

[48]  G. Cheymol,et al.  β and α‐Adrenoceptor Antagonism by Medroxalol in Healthy Volunteers: Relationship to Dose and Plasma Concentration , 1982, Journal of cardiovascular pharmacology.

[49]  J. Whitworth,et al.  "First dose" effect of captopril. , 1982, Australian and New Zealand journal of medicine.

[50]  A. Grahnén,et al.  Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients. , 1982, British journal of clinical pharmacology.

[51]  R. Prescott,et al.  CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION , 1982, The Lancet.

[52]  E. Freis,et al.  Acute and Short‐Term Effects of a New Calcium Antagonist in Hypertension , 1982, Hypertension.

[53]  W. Aronow,et al.  A vasodilator that avoids renin stimulation and fluid retention: Antihypertensive treatment with trimazosin , 1982, Clinical pharmacology and therapeutics.

[54]  J. Laragh,et al.  Long-term efficacy of captopril in renovascular and essential hypertension. , 1982, The American journal of cardiology.

[55]  J. Marniemi,et al.  Effect of pindolol on serum lipids and lipid metabolizing enzymes. , 1982, British journal of clinical pharmacology.

[56]  A. J. Man in 't Veld,et al.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism. , 1982, British journal of clinical pharmacology.

[57]  P. Thompson,et al.  Bronchodilator activity of prazosin in patients with allergic rhinitis and asthma. , 1982, British journal of clinical pharmacology.

[58]  P. Hoff,et al.  One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. , 1982, British medical journal.

[59]  K. Swedberg,et al.  EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION A Double-blind Randomised Trial , 1981, The Lancet.

[60]  N. Takekoshi,et al.  Treatment of severe hypertension and hypertensive emergency with nifedipine, a calcium antagonistic agent. , 1981, Japanese circulation journal.

[61]  E. Sonnenblick,et al.  Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension. , 1981, Chest.

[62]  A. J. Coleman.  EVIDENCE FOR INCREASE IN PERIPHERAL BLOOD FLOW BY INDORAMIN IN MAN , 1981 .

[63]  K. Palmer,et al.  Intravenous indoramin and aerosol salbutamol in bronchial asthma , 1981 .

[64]  B. Gould,et al.  INDORAMIN: 24 HOUR PROFILE OF INTRA-ARTERIAL AMBULATORY BLOOD PRESSURE, A DOUBLE-BLIND PLACEBOCONTROLLED CROSSOVER STUDY , 1981 .

[65]  C. Rosendorff.  Indoramin and hypertension: Clinical studies , 1981 .

[66]  H. Cheng,et al.  Cardiovascular Properties of Medroxalol, A New Antihypertensive Drug , 1981, Journal of cardiovascular pharmacology.

[67]  W. Louis,et al.  Verapamil in the Treatment of Hypertension , 1981, Journal of cardiovascular pharmacology.

[68]  T. Lee,et al.  Measurement of the effects of a single dose of prazosin on the cerebral blood flow in hypertensive patients. , 1980, Postgraduate medical journal.

[69]  W. Kirkendall,et al.  The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. , 1980, Archives of dermatology.

[70]  J. Laragh,et al.  Proteinuria during long-term captopril therapy. , 1980, JAMA.

[71]  B. Rajagopalan,et al.  CAPTOPRIL AND FRUSEMIDE IN SEVERE DRUG-RESISTANT HYPERTENSION , 1980, The Lancet.

[72]  J. Brown,et al.  COMBINED TREATMENT OF SEVERE INTRACTABLE HYPERTENSION WITH CAPTOPRIL AND DIURETIC , 1980, The Lancet.

[73]  R. Cody,et al.  Hemodynamic and Volume Changes Associated with Captopril , 1980, Hypertension.

[74]  H. Gavras,et al.  Clinical Use of an Orally Acting Converting Enzyme Inhibitor: Captopril , 1980, Hypertension.

[75]  N. Christensen,et al.  Comparison of Acute Effects of Nifedipine in Normotensive and Hypertensive Man , 1980, Journal of cardiovascular pharmacology.

[76]  E. Antman,et al.  Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. , 1980, The New England journal of medicine.

[77]  M. Olivari,et al.  Short‐ and Long‐term Efficacy of a Calcium‐antagonistic Agent (Nifedipine) Combined with Methyldopa in the Treatment of Severe Hypertension , 1980, Circulation.

[78]  J. Staessen,et al.  CAPTOPRIL AND AGRANULOCYTOSIS , 1980, The Lancet.

[79]  B. Lown.  Symposium on nifedipine and calcium flux inhibition in the treatment of coronary arterial spasm and myocardial ischemia. Introduction. , 1979, The American journal of cardiology.

[80]  G. Stokes,et al.  Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension , 1979, Clinical pharmacology and therapeutics.

[81]  M. Olivari,et al.  Treatment of Hypertension with Nifedipine, A Calcium Antagonistic Agent , 1979, Circulation.

[82]  B. Hoffbrand.  Peripheral skin necrosis complicating beta-blockade. , 1979, British medical journal.

[83]  F. Finnerty.  Diuretics as initial treatment for essential hypertension. , 1979, British journal of clinical pharmacology.

[84]  T. Dornan,et al.  Peripheral skin necrosis complicating beta-blockage. , 1979, British medical journal.

[85]  A. Chobanian,et al.  A Comparative Study of the Effects of Oxprenolol Versus Propranolol in Essential Hypertension , 1979, Journal of clinical pharmacology.

[86]  T. Yoshida,et al.  Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. , 1978, American heart journal.

[87]  P. Bones,et al.  The treatment of hypertension with verapamil. , 1978, The New Zealand medical journal.

[88]  S. Julius,et al.  Antihypertensive and β‐adrenoceptor antagonist action of timolol , 1978 .

[89]  J. Cruickshank,et al.  Beta-blockers and asthma. , 1978, British heart journal.

[90]  F. Magrini,et al.  Nifedipine, a new antihypertensive with rapid action , 1977, Clinical pharmacology and therapeutics.

[91]  G. Stokes,et al.  Influence of dosage and dietary sodium on the first-dose effects of prazosin. , 1977, British medical journal.

[92]  H. Gavras,et al.  A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MAN , 1977, The Lancet.

[93]  Skidgel Ra,et al.  The angiotensin I-converting enzyme. , 1977 .

[94]  C. Dollery,et al.  The clinical pharmacology of beta-adrenoceptor-blocking drugs. , 1976, Progress in cardiovascular diseases.

[95]  C. Rosendorff.  Prazosin: severe side effects are dose-dependent. , 1976, British medical journal.

[96]  P. Bn,et al.  Labetalol in long-term treatment of hypertension. , 1976 .

[97]  D. Shand,et al.  Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. , 1976, The New England journal of medicine.

[98]  A. Marshall,et al.  Raynaud's phenomenon as side effect of beta-blockers in hypertension. , 1976, British medical journal.

[99]  P. L. Kamburoff.  Bronchomotor tone and its modification by certain drugs , 1976, Postgraduate medical journal.

[100]  M. Pfisterer,et al.  Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. , 1975, The American journal of cardiology.

[101]  M. Bendall,et al.  Side effects due to treatment of hypertension with prazosin. , 1975, British medical journal.

[102]  A. Zanchetti,et al.  Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. , 1975, Clinical science and molecular medicine. Supplement.

[103]  R. Tarazi,et al.  Dissociation Between Renin and Arterial Pressure Responses to Beta‐Adrenergic Blockade in Human Essential Hypertension , 1975, Circulation research.

[104]  C. Johnston,et al.  The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels , 1975, Clinical and experimental pharmacology & physiology.

[105]  G. Matanoski,et al.  HODGKIN'S DISEASE MORTALITY AMONG PHYSICIANS , 1975, The Lancet.

[106]  W. Louis,et al.  Beta-adrenergic receptor blocking drugs, hypertension and plasma renin. , 1975, British journal of clinical pharmacology.

[107]  Chapman Cb.  Letter: Accelerated students. , 1975 .

[108]  G. Ahlmark,et al.  REDUCTION OF SUDDEN DEATHS AFTER MYOCARDIAL INFARCTION , 1974 .

[109]  F. Prime,et al.  Prevention of Exercise-induced Asthma by Indoramin , 1974, British medical journal.

[110]  S. Julius,et al.  Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response. , 1974, International journal of clinical pharmacology, therapy and toxicology.

[111]  R. Elliott.  WRINKLING OF SKIN IN CYSTIC FIBROSIS , 1974 .

[112]  L. Wilhelmsen,et al.  Multivariate Analysis of Risk Factors for Coronary Heart Disease , 1973, Circulation.

[113]  J. Laragh,et al.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. , 1972, The New England journal of medicine.

[114]  L. Beilin,et al.  Alpha and beta adrenergic blockade in hypertension. , 1972, Lancet.

[115]  R. Tarazi,et al.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. , 1972, The American journal of cardiology.

[116]  A. W. Johnston,et al.  Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison , 1968, British medical journal.

[117]  W. Belton.  Consultants' views of general practitioners , 1967 .

[118]  Saunders Kb.  END--OR BEGINNING? , 1965 .

[119]  E. Adkins,et al.  Enalapril in Experimental Hypertension and Acute Heart Failure: Comparison with Calcium Channel Blockers , 1986, Journal of cardiovascular pharmacology.

[120]  A. Khandwala,et al.  Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties. , 1986, Journal of cardiovascular pharmacology.

[121]  S. Taylor,et al.  Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease. , 1986, Journal of cardiovascular pharmacology.

[122]  J. Biollaz,et al.  Chronic Treatment of Hypertensive Patients with Converting Enzyme Inhibitors , 1986, Journal of cardiovascular pharmacology.

[123]  P. Capone,et al.  A placebo-controlled double-blind multicenter study of celiprolol in the treatment of mild and moderate hypertension. , 1986, Journal of cardiovascular pharmacology.

[124]  Shanks Rg.  The clinical pharmacology of indoramin. , 1986 .

[125]  R. Solomon.  Antihypertensive Effects of Indoramin and Prazosin in Combination with Hydrochlorothiazide , 1986, Journal of cardiovascular pharmacology.

[126]  C. Ford,et al.  Cardiovascular morbidity and mortality in HDFP patients 50-69 years old at entry. , 1985, Journal of cardiovascular pharmacology.

[127]  A. Lant.  Diuretics , 2012, Drugs.

[128]  B. Waeber,et al.  The present molecules of converting enzyme inhibitors. , 1985, Journal of cardiovascular pharmacology.

[129]  P. Lund-johansen.  Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol. , 1984, Drugs.

[130]  R. N. Brogden,et al.  Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. , 1984, Drugs.

[131]  Beevers Dg,et al.  Nifedipine in combination therapy for resistant hypertension. , 1983 .

[132]  C. P. Hsieh,et al.  Vasodilation by medroxalol mediated by beta 2-adrenergic receptor stimulation. , 1983, Journal of cardiovascular pharmacology.

[133]  J. Stessman,et al.  The combination of propranolol and nifedipine in the treatment of hypertension: acute and long term effects. , 1983, Postgraduate medical journal.

[134]  R. Erbel,et al.  Emergency treatment of hypertensive crisis with sublingual nifedipine. , 1983, Postgraduate medical journal.

[135]  E. Myhre,et al.  The effects of nifedipine, a calcium antagonist, on platelet function. , 1983, American heart journal.

[136]  S. Rössner.  Serum Lipoproteins and Ischemic Vascular Disease: On the Interpretation of Serum Lipid Versus Serum Lipoprotein Concentrations , 1982, Journal of cardiovascular pharmacology.

[137]  C. Johnston,et al.  Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension. , 1982, Clinical and experimental pharmacology & physiology. Supplement.

[138]  C. Barter,et al.  A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease. , 1982, Journal of cardiovascular pharmacology.

[139]  F. Follath,et al.  Serum concentration and antihypertensive effect of slow-release verapamil. , 1982, Journal of cardiovascular pharmacology.

[140]  D. Gori,et al.  Antihypertensive Effect of Tiapamil, a Calcium Antagonist , 1982 .

[141]  J. R. Knill.  The development of captopril and its role in the treatment of hypertension. , 1982, Clinical and experimental pharmacology & physiology. Supplement.

[142]  S. Taylor.  Alpha-Adrenoceptor Antagonists in Hypertension , 1982 .

[143]  B. Gould,et al.  Slow channel inhibitors verapamil and nifedipine in the management of hypertension. , 1982, Journal of cardiovascular pharmacology.

[144]  M. Castellano,et al.  Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension. , 1982, Journal of cardiovascular pharmacology.

[145]  J. Chalmers,et al.  Increased Noradrenaline (na) Concentration in Cerebellum and Spinal-Cord of Stroke-Prone Spontaneously Hypertensive Rats , 1980 .

[146]  D. Richards,et al.  Clinical pharmacology of labetalol. , 1979, British journal of clinical pharmacology.

[147]  A. Morganti,et al.  Interactions between diuretics and propranolol in treatment of arterial hypertension , 1979 .

[148]  B. Prichard,et al.  The Use of Beta-Adrenoceptor Blocking Drugs in Hypertension: A Review , 1977 .

[149]  I. Stewart.  Compared incidence of first myocardial infarction in hypertensive patients under treatment containing propranolol or excluding beta-receptor blockade. , 1976, Clinical science and molecular medicine. Supplement.

[150]  L. Hansson.  Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity. , 1973, Acta medica Scandinavica. Supplementum.

[151]  W. Birkenhäger,et al.  Antihypertensive effects of propranolol. Observations on predictability. , 1971, Folia medica Neerlandica.